Cumberland Pharmaceuticals (CPIX) EBIT (QoQ) (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Cumberland Pharmaceuticals | 116.48 Mn | 112.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.00% |
| Mar 31, 2026 | -128.22% |
| Dec 31, 2025 | 30.23% |
| Sep 30, 2025 | -162.92% |
| Jun 30, 2025 | -157.86% |
| Mar 31, 2025 | 170.14% |
| Dec 31, 2024 | -8.71% |
| Sep 30, 2024 | -65.04% |
| Jun 30, 2024 | 45.07% |
| Mar 31, 2024 | 69.75% |
| Dec 31, 2023 | -231.04% |
| Sep 30, 2023 | -8,265.72% |
| Jun 30, 2023 | 101.49% |
| Mar 31, 2023 | 32.76% |
| Dec 31, 2022 | -689.29% |
| Sep 30, 2022 | 84.37% |
| Jun 30, 2022 | -42.92% |
| Mar 31, 2022 | 70.33% |
| Dec 31, 2021 | -178.50% |
| Sep 30, 2021 | -8.89% |